Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

atrial fibrillation/kalium

Der Link wird in der Zwischenablage gespeichert
12 Ergebnisse

Thieno[3,2-c]pyridine potassium channel inhibitors

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to thienopyridine compounds which are potassium channel inhibitors. Pharmaceutical compositions comprising the compounds and their use in the treatment or prevention of cancer, arrhythmias, autoimmune diseases and

Compounds and their use as IKACh blockers

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
TECHNICAL FIELD The present invention relates to a novel class of compounds which are pharmacologically effective as potassium channel inhibitors, in particular inhibitors of the acetylcholine operated inward rectifying potassium channel current, i.e. IKACh blockers. The invention also relates to
This application is a national stage application under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2011/065,713, filed Sep. 12, 2011, the disclosure of which is explicitly incorporated by reference herein. The invention relates to 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine
The invention relates to 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine compounds of the formula I, ##STR00002## The compounds of formula I act on the TASK-1 (KCNK3) potassium channel. The compounds are suitable for the treatment of several pathologies and particularly suitable as antiarrhythmic
This application is a national stage application under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2011/066061, filed Sep. 16, 2011, the disclosure of which is explicitly incorporated by reference herein. The invention relates to 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine compounds

Fused pyrroledicarboxamides and their use as pharmaceuticals

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The present invention relates to fused pyrroledicarboxamides of the formula I, ##STR00002## in which R1 to R9, X, m and n are as defined below. The compounds of the formula I are inhibitors of the acid-sensitive potassium channel TASK-1 and suitable for the treatment of TASK-1 channel-mediated

Fused pyrroledicarboxamides and their use as pharmaceuticals

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This application is a national stage application under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2013/051996, filed Feb. 1, 2013, the disclosure of which is explicitly incorporated by reference herein. The present invention relates to fused pyrroledicarboxamides of the formula
The invention relates to compounds of formula I ##STR2## in which R(8) is either a 1-indanyl radical of formula II or a 2-indanyl radical of formula III ##STR3## and in which R(1), R(2), R(3), R(4), R(5), R(6), R(7), R(9), R(10), R(11), R(12), R(13), R(14), and R(15) have the meanings stated below,

Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
DESCRIPTION The invention relates to compounds of formula I, represented in the structure below, in which R1, R2, R3, R4, R5, R6 and R7 have the meanings as stated below, and to the use thereof, especially in pharmaceuticals. ##STR00002## The present invention encompasses compounds of formula I

Anthranilamides and methods of their use

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The invention relates to compounds of formula I, ##STR00002## in which R(1), R(2), R(3), R(4), R(5), R(6) and R(7) have the meanings indicated hereinafter, to their preparation and use, and in particular, to their use as pharmaceuticals. The compounds of formula I have not previously been disclosed.

Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This application claims the priority of German application No. 10128331.8, filed on Jun. 12, 2001, under 35 U.S.C. 119, which is incorporated by reference. DESCRIPTION The invention relates to compounds of formula I, represented in the structure below, in which R1, R2, R3, R4, R5, R6 and R7 have the

Anthranilamides and methods of their use

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This application is a CON of 10/132,163, filed Apr. 26, 2002. The invention relates to compounds of formula I, ##STR00002## in which R(1), R(2), R(3), R(4), R(5), R(6) and R(7) have the meanings indicated hereinafter, to their preparation and use, and in particular, to their use as
Treten Sie unserer
Facebook-Seite bei

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird

  • Arbeitet in 55 Sprachen
  • Von der Wissenschaft unterstützte Kräuterkuren
  • Kräutererkennung durch Bild
  • Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
  • Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
  • Suchen Sie nach Heilkräutern nach ihrer Wirkung
  • Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden

Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen

Google Play badgeApp Store badge